Harrow, Inc. (HROW)
Makes and sells prescription eye drops and medications for treating eye diseases.
$39.32+0.05%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+25.9%
The outlook
HROW trades at $39.32, sitting roughly midway in its 52-week range with mixed momentum against its moving averages. Analyst consensus is Strong Buy, with an average price target around 72% above the current level. The overall lean is bullish based on available data.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 8 analysts
Price trendMixed vs its moving averages
52-week range41% of the way from its 52-week low to high
Price targetAvg target +72% vs current price
Analyst price target
~12-month · 8 analysts$67.75average target+72.3% vs now
Now $39.32
Low $59.00High $88.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.47B
52-wk high
$54.85
52-wk low
$28.54
50-day avg
$38.73
200-day avg
$41.11
Trailing P/E
—